I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Association between immune-related adverse event timing and..:
David Hsiehchen
;
Abdul Rafeh Naqash
;
Magdalena Espinoza
...
http://dx.doi.org/10.1080/2162402X.2021.2017162. , 2022
Link:
https://doi.org/10.1080/2162402X.2021.2017162
RT Journal T1
Association between immune-related adverse event timing and treatment outcomes
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:314b3c66dd194bac9be88d3b95ef3bff&Exemplar=1&LAN=DE A1 David Hsiehchen A1 Abdul Rafeh Naqash A1 Magdalena Espinoza A1 Mitchell S. Von Itzstein A1 Alessio Cortellini A1 Biagio Ricciuti A1 Dwight H. Owen A1 Mehak Laharwal A1 Yukihiro Toi A1 Michael Burke A1 Yang Xie A1 David E. Gerber PB Taylor & Francis Group YR 2022 K1 immune checkpoint inhibitor K1 immune-related adverse event K1 latency K1 predictive marker K1 Immunologic diseases. Allergy K1 RC581-607 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://dx.doi.org/10.1080/2162402X.2021.2017162 LK http://dx.doi.org/https://doi.org/10.1080/2162402X.2021.2017162 DO https://doi.org/10.1080/2162402X.2021.2017162 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)